Answer
Excitement, irritability and sedation have been reported in breastfed infants presumably exposed to Xonvea’s doxylamine through breast milk; infants with apnoea or other respiratory syndromes may be particularly vulnerable to sedation that worsens their conditions.
Sources for this answer
- Xonvea 10 mg/10 mg gastro-resistant tabletsExeltis UK Ltd · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 2Document updated
Sources checked